Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial

Long-term Effects of Ranibizumab on Diabetic Retinopathy Severity and Progression

(2012) Michael S. Ip   ARCHIVES OF OPHTHALMOLOGY

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

(2012) Daniel F. Martin et al.   OPHTHALMOLOGY

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration

(2012) Usha Chakravarthy et al.   OPHTHALMOLOGY

An investigation of the construct validity of the ICECAP-A capability measure

(2012) Hareth Al-Janabi et al.   QUALITY OF LIFE RESEARCH

Treatment of proliferative diabetic retinopathy with anti-VEGF agents

(2011) Aysha Salam et al.   ACTA OPHTHALMOLOGICA

Intraocular Oxygen Distribution in Advanced Proliferative Diabetic Retinopathy

(2011) Clemens A.K. Lange et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Psychometric development of the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ)

(2010) Leonie S. Brose et al.   Psychology Health & Medicine

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

(2009) V H Gonzalez et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Psychometric Development of the Individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL)

(2009) Leonie S. Brose et al.   VALUE IN HEALTH

Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods

(2008) M. F. Janssen et al.   QUALITY OF LIFE RESEARCH